Sundstrom, Rachel
Wetherill, Leah http://orcid.org/0000-0003-2888-9051
Sapp, Katie
McPheron, Molly
Lah, Melissa http://orcid.org/0000-0002-2406-8961
Article History
Received: 11 June 2023
Accepted: 29 August 2023
First Online: 6 October 2023
Declarations
:
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5).
: Informed consent was obtained from all patients for being included in the study.
: Melissa Lah is a primary investigator on clinical trials for PKU with BioMarin Pharmaceutical Inc., Homology Medicines Inc. and PTC Therapeutics. Melissa Lah also serves on Palynziq related advisory boards for BioMarin Pharmaceutical Inc.Rachel Sundstrom, Leah Wetherill, Katie Sapp, and Molly McPheron declare that they have no conflict of interest.